May 16, 2019
Henkel strengthens additive manufacturing portfolio
Henkel announced the acquisition of Molecule Corp., a privately owned, technology-driven enterprise focused on product innovation in additive manufacturing.
Molecule Corp. provides advanced solutions for 3D printing applications – including medical device, aerospace, automotive and a wide variety of consumer goods – as well as industrial inkjet materials, impacting a wide variety of markets. The US-based company is headquartered in Concord (CA), in the San Francisco Bay Area.
“Molecule Corp. and Henkel are an excellent fit”, says Philipp Loosen, Head of 3D Printing at Henkel. “Molecule’s strong 3D printing and inkjet resin technologies and digital development capabilities perfectly complement and strengthen our materials portfolio and build on our approach to offer a comprehensive range of customized additive manufacturing solutions.”
“Molecule’s technology and engineering center in California also broadens our global 3D printing footprint. We now provide 3D printing support to our customers in all major regions around the world.”, adds Michael Todd, Head of Innovation at Henkel Adhesives Technologies.
“We are excited to join Henkel”, says Ken Kisner, Founder and President of Molecule Corp. “Henkel’s customer centered approach along with our combined product portfolio will help key industries accelerate the speed of innovation and move 3D printing from prototyping to digital manufacturing.” Molecule Corp. will already be present at Henkel´s booth during the upcoming Rapid + TCT show from May 21 to 23 in Detroit, MA.
The acquisition is in line with Henkel’s strategy to strengthen its portfolio through targeted acquisitions. It is complementing and strengthening Henkel’s technology portfolio for durable & functional parts in additive manufacturing (3D printing). It also enhances Henkel’s capacities to invent and develop new material or material components and grants access to industrial inkjet applications.
Both parties agreed to not disclose any financial details of the transaction.